Evidence for effectiveness of a national HPV vaccination programme: National prescription data from New Zealand

Sexually Transmitted Infections

Volumn 90, Issue 2, 2014, Pages 103-

  Wilson, Nick ^a   Morgan, Jane ^b   Baker, Michael G ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b WAIKATO DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; WART VIRUS VACCINE;

CONDYLOMA ACUMINATUM; HUMAN; LETTER; NEW ZEALAND; PAPILLOMAVIRUS INFECTION; PRESCRIPTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

GENITAL WARTS; HPV; PREVENTION; PUBLIC HEALTH; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; CHILD; CONDYLOMATA ACUMINATA; DRUG PRESCRIPTIONS; FEMALE; HUMANS; NEW ZEALAND; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PHARMACIES; PODOPHYLLOTOXIN; PROGRAM EVALUATION; TREATMENT OUTCOME; VACCINATION;

EID: 84895537178     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2013-051037     Document Type: Letter

References (1)

1. Leval A, Herweijer E, Arnheim-Dahlstrom L, et al. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis 2012;206:860-6